Expression of drug targets in primary and matched metastatic renal cell carcinoma tumors

BACKGROUND: Targeted therapies in renal cell carcinoma can have different effects on primary and metastatic tumors. To pave the way for predictive biomarker development, we assessed differences in expression of targets of currently approved drugs in matched primary and metastatic specimens from 34 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Aziz, Saadia A, Sznol, Joshua A, Adeniran, Adebowale, Parisi, Fabio, Kluger, Yuval, Camp, Robert L, Kluger, Harriet M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575219/
https://www.ncbi.nlm.nih.gov/pubmed/23374878
http://dx.doi.org/10.1186/1472-6890-13-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575219/
https://www.ncbi.nlm.nih.gov/pubmed/23374878
http://dx.doi.org/10.1186/1472-6890-13-3

Ejemplares similares